Cost-effectiveness Analysis of Durvalumab Combined with Tremelimumab in the First-line Treatment of Advanced Hepatocellular Carcinoma

CHEN Qiuping,SHAO Mingyi,CUI Hongyan,LYU Lanqing,CHEN Xiaoqi

Herald of Medicine ›› 2023, Vol. 42 ›› Issue (10) : 1492-1497.

PDF(1915 KB)
中国科技论文统计源期刊　中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库（JST）
第七届湖北十大名刊提名奖  
PDF(1915 KB)
Herald of Medicine ›› 2023, Vol. 42 ›› Issue (10) : 1492-1497. DOI: 10.3870/j.issn.1004-0781.2023.10.012

Cost-effectiveness Analysis of Durvalumab Combined with Tremelimumab in the First-line Treatment of Advanced Hepatocellular Carcinoma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 42(10): 1492-1497 https://doi.org/10.3870/j.issn.1004-0781.2023.10.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1915 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉